TW297023B - - Google Patents
Download PDFInfo
- Publication number
- TW297023B TW297023B TW083106150A TW83106150A TW297023B TW 297023 B TW297023 B TW 297023B TW 083106150 A TW083106150 A TW 083106150A TW 83106150 A TW83106150 A TW 83106150A TW 297023 B TW297023 B TW 297023B
- Authority
- TW
- Taiwan
- Prior art keywords
- indoline
- methyl
- chloro
- pyridylaminecarboxamido
- nmr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Eyeglasses (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939313913A GB9313913D0 (en) | 1993-07-06 | 1993-07-06 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW297023B true TW297023B (cg-RX-API-DMAC7.html) | 1997-02-01 |
Family
ID=10738344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083106150A TW297023B (cg-RX-API-DMAC7.html) | 1993-07-06 | 1994-07-05 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5834494A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0707581B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH08512299A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1129937A (cg-RX-API-DMAC7.html) |
| AP (1) | AP463A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE149163T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU7228394A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2166624A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69401823T2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB9313913D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL110204A0 (cg-RX-API-DMAC7.html) |
| MA (1) | MA23254A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW297023B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1995001976A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA944807B (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618824A (en) * | 1994-03-09 | 1997-04-08 | Merrell Pharmaceuticals Inc. | Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
| GB9414139D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Novel compounds |
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| BR9607016A (pt) * | 1995-02-02 | 1997-10-28 | Smithkline Beecham Plc | Derivados de indol como antagonísta de receptor 5-ht |
| WO1996023769A2 (en) * | 1995-02-02 | 1996-08-08 | Smithkline Beecham Plc | Heterocyclic compounds possessing 5ht2c receptor antagonist activity |
| GB9517559D0 (en) * | 1995-08-26 | 1995-10-25 | Smithkline Beecham Plc | Novel compounds |
| CA2253941A1 (en) * | 1996-05-16 | 1997-11-20 | Sumanas Rakhit | Thiophene- and furan-tryptamine derivatives |
| GB9612883D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| GB9612885D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| US6362009B1 (en) | 1997-11-21 | 2002-03-26 | Merck & Co., Inc. | Solid phase synthesis of heterocycles |
| FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1122252A4 (en) * | 1998-10-16 | 2002-06-26 | Takeda Chemical Industries Ltd | CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM |
| US6453357B1 (en) | 1999-01-07 | 2002-09-17 | Cisco Technology, Inc. | Method and system for processing fragments and their out-of-order delivery during address translation |
| US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| ES2252004T3 (es) * | 1999-05-21 | 2006-05-16 | Biovitrum Ab | Nuevos compuestos, su uso y preparacion. |
| UA77650C2 (en) | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| FR2810979B1 (fr) * | 2000-06-29 | 2002-08-23 | Adir | Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0019950D0 (en) * | 2000-08-12 | 2000-09-27 | Smithkline Beecham Plc | Compounds |
| SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| EP1304589A1 (en) * | 2001-07-09 | 2003-04-23 | Alcatel | Connector for optical fibers |
| US6861440B2 (en) | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
| FR2837823B1 (fr) * | 2002-03-27 | 2005-04-08 | Servier Lab | Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| NZ536664A (en) | 2002-06-19 | 2007-07-27 | Biovitrum Ab | Piperazinylpyrazine derivative compounds, their use and preparation |
| BRPI0411509A (pt) | 2003-06-20 | 2006-07-25 | Hoffmann La Roche | compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização |
| EA009591B1 (ru) | 2003-06-20 | 2008-02-28 | Ф.Хоффманн-Ля Рош Аг | Производные пиридо[2,1-а]изохинолина в качестве ингибиторов dpp-iv |
| AR058040A1 (es) * | 2005-09-13 | 2008-01-23 | Bayer Cropscience Ag | Derivados plaguicidas de fenilamidina sustituida con feniloxi |
| US8293100B2 (en) | 2009-03-13 | 2012-10-23 | Terrasep, Llc | Methods and apparatus for centrifugal liquid chromatography |
| CN106278987A (zh) * | 2016-08-16 | 2017-01-04 | 都创(上海)医药科技有限公司 | 吲哚啉类化合物的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428881A (en) * | 1977-12-23 | 1984-01-31 | Gulf Oil Corporation | Control of unwanted vegetation with N-carbamylindolines |
| KR930702334A (ko) * | 1990-09-13 | 1993-09-08 | 데이비드 로버트 | 5 하이드록시트립타민 수용체 길항제로서의 인돌우레아 |
| CA2142721A1 (en) * | 1992-08-20 | 1994-03-03 | Ian T. Forbes | Condensed indole derivatives as 5ht and 5ht antagonists |
-
1993
- 1993-07-06 GB GB939313913A patent/GB9313913D0/en active Pending
-
1994
- 1994-06-30 AU AU72283/94A patent/AU7228394A/en not_active Abandoned
- 1994-06-30 CN CN94193185A patent/CN1129937A/zh active Pending
- 1994-06-30 WO PCT/EP1994/002148 patent/WO1995001976A1/en not_active Ceased
- 1994-06-30 CA CA002166624A patent/CA2166624A1/en not_active Abandoned
- 1994-06-30 JP JP7503812A patent/JPH08512299A/ja active Pending
- 1994-06-30 EP EP94921638A patent/EP0707581B1/en not_active Expired - Lifetime
- 1994-06-30 DE DE69401823T patent/DE69401823T2/de not_active Expired - Fee Related
- 1994-06-30 AT AT94921638T patent/ATE149163T1/de not_active IP Right Cessation
- 1994-07-04 MA MA23564A patent/MA23254A1/fr unknown
- 1994-07-04 ZA ZA944807A patent/ZA944807B/xx unknown
- 1994-07-04 IL IL11020494A patent/IL110204A0/xx unknown
- 1994-07-04 AP APAP/P/1994/000653A patent/AP463A/en active
- 1994-07-05 TW TW083106150A patent/TW297023B/zh active
-
1996
- 1996-09-23 US US08/717,957 patent/US5834494A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69401823D1 (de) | 1997-04-03 |
| EP0707581A1 (en) | 1996-04-24 |
| AP9400653A0 (en) | 1994-07-31 |
| ATE149163T1 (de) | 1997-03-15 |
| WO1995001976A1 (en) | 1995-01-19 |
| AU7228394A (en) | 1995-02-06 |
| JPH08512299A (ja) | 1996-12-24 |
| US5834494A (en) | 1998-11-10 |
| IL110204A0 (en) | 1995-01-24 |
| CA2166624A1 (en) | 1995-01-19 |
| GB9313913D0 (en) | 1993-08-18 |
| DE69401823T2 (de) | 1997-08-28 |
| ZA944807B (en) | 1996-01-04 |
| EP0707581B1 (en) | 1997-02-26 |
| CN1129937A (zh) | 1996-08-28 |
| AP463A (en) | 1996-02-19 |
| MA23254A1 (fr) | 1995-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW297023B (cg-RX-API-DMAC7.html) | ||
| TW520989B (en) | Pharmaceutical composition for treating dementia, dementia of the Alzheimer's type, dyskinesias and behavioral manifestations of mental retardation, conduct disorder and autistic disorder | |
| TWI296625B (en) | Novel cyclic amide derivatives | |
| US4282233A (en) | Antihistaminic 11-(4-piperidylidene)-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridines | |
| CN101384550B (zh) | 酰胺衍生物或其盐 | |
| ES2296763T3 (es) | Pirrolidinas disustituidas en 1,3 como amtagonistas de adrenorreceptor alfa-2. | |
| DE60108633T2 (de) | 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin v1b und v1a rezeptoren | |
| JP2005527463A (ja) | Ｃｎｓ疾患を治療するための５−ｈｔ６受容体アフィニティーを有する３−アリールスルホニル−７−ピペラジニル−インドール、−ベンゾフランおよび−ベンゾチオフェン | |
| CA2045359C (en) | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines | |
| JPS61191683A (ja) | 新規な酸性インド−ル化合物 | |
| TW200418843A (en) | Viral polymerase inhibitors | |
| ES2221886T3 (es) | Derivados de la 1,3-dihidro-2h-indol-2-ona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| JP2005507872A (ja) | ３−置換オキシインドールβ３アゴニスト | |
| JPH06509574A (ja) | ５−ｈｔ↓４レセプターアンタゴニスト | |
| HUP0104280A2 (hu) | Dopamin D3 receptorok modulátoraiként felhasználható tetrahidrobenzazepin-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0001123A2 (hu) | Kombinált 5HT1A, 5HT1B és 5HT1D receptor antagonista aktivitással rendelkező indolszármazékok | |
| CZ20021038A3 (cs) | Piperazinové deriváty jako antagonisté 5-HT1B | |
| JPH06505238A (ja) | ３−ピペリジニルメチルカルボキシレート置換インドール | |
| JP6434528B2 (ja) | 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用 | |
| HU217590B (hu) | Eljárás 6-os helyen heterociklusos csoporttal helyettesített 4-amino-1,3,4,5-tetrahidro-benz[c,d]indolok és a vegyületeket tartalmazó gyógyszerkészítmények előállítására | |
| ES2562903T3 (es) | Nuevo compuesto que tiene actividad inhibidora de PARP | |
| CN101384549B (zh) | 吡咯衍生物或其盐 | |
| JPH09509957A (ja) | 免疫調節剤としてのキノリン誘導体 | |
| TW487706B (en) | 3-benzylpiperidines | |
| CN112041300B (zh) | 作为双重5-ht2a和5-ht6受体拮抗剂的吲哚和苯并咪唑衍生物 |